New cancer clinical trial: Thromboprophylaxis With Rivaroxaban In Patients With Malignancy and Central Venous Lines

Published on: April 24, 2018 at 12:00PM
Conditions:   Upper Extremity Deep Vein Thrombosis;   Central Venous Catheter Thrombosis;   Cancer
Intervention:   Drug: Rivaroxaban 10 MG
Sponsors:   Ottawa Hospital Research Institute;   Queen Elizabeth II Health Sciences Centre;   University of Alberta
Not yet recruiting
https://ift.tt/2HqDijg